Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

More people living with MS, according to study


A growing number of people in the UK are living with multiple sclerosis (MS), despite decreases in those being newly diagnosed with the condition, a study has found.

Researchers at the University of Dundee analysed data spanning two decades from GP surgeries across the country.

They found that between 1990 and 2010, the number of people living with MS increased by about 2.4% a year, even though there was a fall in the numbers being diagnosed.

The reason is that people with MS are living longer, with mortality rates falling by about 3% per year over the same 20-year period, according to the study.

The findings have “important implications” for resource allocation for MS in the UK, the researchers said.

MS is a neurological disease with no cure in which the coating of the nerve fibres is damaged, causing a range of symptoms.

It can lead to high levels of disability and impaired life quality.

The costs of the disease in the UK, including health and social care and productivity losses, are “high” and correlate with the severity of the disease, the study said.

In the research paper, published by the British Medical Journal, an outline of the study’s principal findings stated: “We estimate that the prevalence of MS in the UK in 2010, including diagnoses obtained from Hospital Episode Statistics (HES), was 289 per 100,000 in women and 115 per 100,000 in men.

“The overall prevalence of MS increased by approximately 2.4% per year between 1990 and 2010 in women and men.

“This increase in prevalence was due to a convergence of absolute mortality rates in patients with and without MS, the result of mortality rates falling by about 3% per year in both groups.”

The paper continued: “We observed a decline in the rate at which new cases of MS were diagnosed, and the rising prevalence rate can likely be accounted for by trends in mortality rates.”

In other findings, researchers estimate that, in the UK, just over 6,000 people were diagnosed with MS during 2010 and there were nearly 127,000 people living with the condition that year.

The peak age at which the condition was diagnosed was between 40 and 50.

Multiple sclerosis was also found to be much more common in women than in men, with 72% of those living with MS in 2010 being female.

It was also more common in Scotland than in other parts of the UK.

Dr Isla Mackenzie, clinical senior lecturer at the university’s medicines monitoring unit, led the study.

She said, “Our research covers four million patients from a representative sample of GP practices spread throughout the UK.

“This study provides an up to date national picture of the epidemiology of MS in the UK.

“It is important to have this information on the prevalence of MS in order to understand the impact of this disease and to ensure that adequate resources are provided both nationally and regionally for people affected by MS.”

Dr Jonathan O’Riordan, consultant neurologist at Ninewells Hospital in Dundee, said: “There are probably genetic and environmental factors at play to explain why it is more common in Scotland.

“The vast majority of newly diagnosed patients will have the relapsing remitting form of the disease and will be eligible for consideration of disease-modifying therapies.

“These can cost anywhere from £5,500 to nearly £20,000 per year.

“This has ongoing cost implications for healthcare providers.”

The study used data from the General Practice Research Database, which contains patient records from 8% of GP practices in the UK.

It was funded by the Multiple Sclerosis National Therapy Centres (MSNTC), a registered charity.

MSNTC chairman Neil Kemsley said: “As more people in the UK are living longer with MS, the help and support provided by the network of therapy centres throughout the country will become even more valuable and important in helping them to achieve the best possible quality of life.”


Are you able to Speak out Safely?

Sign our petition to put pressure on your trust to support an open and transparent NHS


Readers' comments (2)

  • tinkerbell

    Will every illness have a price tag attached to it? How will this effect us? If you have a pre-existing condition you will not be covered by private health care insurance. Your GP may not want to keep you on their books because you are a drain on their budget. What could possibly go wrong? Sick and financially stressed too whilst trying to find a way to pay for medical bills, where does that happen, oh yes good old USA.

    Unsuitable or offensive? Report this comment

  • if patients have to come to rely on private insurance in the future obviously a European model would have to be considered such as obligatory insurance for all residents of the country where all basic medical costs are covered and any excesses and premiums are controlled through income tax deductions, and with financial support for those whose earnings are below a certain threshold. Some of these schemes may be partially funded by patients through their premiums and partially be the state. there are many different models available and choice in policies best suited to each individual.

    it isn't all negative, although knowing the inability in the UK to manage anything this is questionable. many countries with such a system have far better and more comprehensive healthcare than in the UK and it need cost the taxpayer no more than the current UK system.

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.